These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9779381)

  • 1. Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus, and gram-negative rods.
    Low DE
    Infect Dis Clin North Am; 1998 Sep; 12(3):613-30, viii. PubMed ID: 9779381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistance to macrolides, lincosamides and streptogramins in infections by Streptococcus pneumoniae].
    Alonso Manzanares MA; Gutíerrez Zufiaurre MN; Muñoz Bellido JL; García-Rodríguez JA
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():25-30. PubMed ID: 9717157
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group.
    Schmitz FJ; Verhoef J; Fluit AC
    J Antimicrob Chemother; 1999 Jun; 43(6):783-92. PubMed ID: 10404317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for treatment of pneumonia in intensive care units].
    Emmi V
    Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
    Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus pneumoniae: epidemiology and patterns of resistance.
    Jacobs MR
    Am J Med; 2004 Aug; 117 Suppl 3A():3S-15S. PubMed ID: 15360092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of pristinamycin treatment in a case of pneumonia caused by a streptogramins B-type resistant pneumococcus.
    Brevet-Coupe F; Guerin B; Watine J
    Scand J Infect Dis; 1998; 30(4):419-20. PubMed ID: 9817526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of quinupristin/dalfopristin (Synercid) against isolates of Streptococcus pneumoniae, Staphylococcus aureus and enterococcus spp.
    Johnson AP; Warner M; Speller DC
    J Antimicrob Chemother; 1997 Oct; 40(4):604-5. PubMed ID: 9372437
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
    Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution and present situation of Staphylococcus aureus sensitivity to MLS in hospital (1975-83).
    Thabaut A; Meyran M; Huerre M
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():205-7. PubMed ID: 3932304
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia.
    Chenoweth CE; Saint S; Martinez F; Lynch JP; Fendrick AM
    Mayo Clin Proc; 2000 Nov; 75(11):1161-8. PubMed ID: 11075746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial pathogens of adult community-acquired pneumonia in Southern Estonia.
    Leesik H; Ani U; Juhani A; Altraja A
    Medicina (Kaunas); 2006; 42(5):384-94. PubMed ID: 16778466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial Lining Fluid and Plasma Concentrations of Dalbavancin in Healthy Adults after a Single 1,500-Milligram Infusion.
    Rappo U; Dunne MW; Puttagunta S; Baldassarre JS; Su S; Desai-Krieger D; Inoue M
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.
    Depardieu F; Courvalin P
    Antimicrob Agents Chemother; 2001 Jan; 45(1):319-23. PubMed ID: 11120988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
    Jones RN; Pfaller MA; Doern GV; Erwin ME; Hollis RJ
    Diagn Microbiol Infect Dis; 1998 Mar; 30(3):215-28. PubMed ID: 9572029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible pseudoresistance of Streptococcus pneumoniae to penicillin G in a patient with a mixed pneumococcus-Staphylococcus aureus pneumonia.
    Drelichman V; Cushing RD; Bawdon RE; Lerner AM
    Am J Med Sci; 1984; 287(3):39-43. PubMed ID: 6610355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial aetiology and outcome in children with severe pneumonia in Uganda.
    Nantanda R; Hildenwall H; Peterson S; Kaddu-Mulindwa D; Kalyesubula I; Tumwine JK
    Ann Trop Paediatr; 2008 Dec; 28(4):253-60. PubMed ID: 19021940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance among Streptococcus pneumoniae: Implications for drug selection.
    Appelbaum PC
    Clin Infect Dis; 2002 Jun; 34(12):1613-20. PubMed ID: 12032897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory infections due to drug-resistant bacteria.
    Song JH; Chung DR
    Infect Dis Clin North Am; 2010 Sep; 24(3):639-53. PubMed ID: 20674796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.